ArticleJournal of diabetes investigation2012

The once-daily human glucagon-like peptide-1 analog, liraglutide, improves β-cell function in Japanese patients with type 2 diabetes.

Yutaka Seino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.